Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 2 (2005), Issue 7 (July)

1. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography.
   J Womens Health (Larchmt), 14(5): 410-7. [Abstract] [Full-text]
2. The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
   Eur J Obstet Gynecol Reprod Biol, 121(1): 61-6. [Abstract] [Full-text]
3. Sexual activity and function in postmenopausal women with heart disease.
   Obstet Gynecol, 106(1): 121-7. [Abstract] [Full-text]
4. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
   Skin Res Technol, 11(3): 201-4. [Abstract] [Full-text]
5. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
   J Clin Endocrinol Metab, 90(7): 3978-82. [Abstract] [Full-text]
6. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine.
   J Clin Endocrinol Metab, 90(7): 4057-62. [Abstract] [Full-text]
7. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
   J Clin Endocrinol Metab, 90(7): 3946-55. [Abstract] [Full-text]
8. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.
   J Clin Endocrinol Metab, 90(7): 3989-94. [Abstract] [Full-text]
9. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
   J Clin Endocrinol Metab, 90(7): 3877-85. [Abstract] [Full-text]
10. Symptom experience after discontinuing use of estrogen plus progestin.
    JAMA, 294(2): 183-93. [Abstract] [Full-text]
11. Menopausal hormones and risk of ovarian cancer.
    Am J Obstet Gynecol, 193(1): 76-82. [Abstract] [Full-text]
12. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.
    Am J Obstet Gynecol, 193(1): 58-63. [Abstract] [Full-text]
13. Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
    Gynecol Endocrinol, 20(6): 336-42. [Abstract] [Full-text]
14. Menopause and dry eye. A possible relationship.
    Gynecol Endocrinol, 20(5): 289-98. [Abstract] [Full-text]
15. Percutaneous administration of testosterone gel in postmenopausal women--a pharmacological study.
    Gynecol Endocrinol, 20(5): 243-8. [Abstract] [Full-text]
16. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels.
    Gynecol Endocrinol, 20(4): 227-35. [Abstract] [Full-text]
17. Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers.
    Gynecol Endocrinol, 20(4): 221-6. [Abstract] [Full-text]
18. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Gynecol Endocrinol, 20(4): 209-12. [Abstract] [Full-text]
19. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Gynecol Endocrinol, 20(3): 176-82. [Abstract] [Full-text]
20. Hormone replacement therapy: one-year follow up of DNA damage.
    Mutat Res, 585(1): 14-20. [Abstract] [Full-text]
21. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review.
    Hum Reprod, 20(8): 2052-60. [Abstract] [Full-text]
22. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Cancer Epidemiol Biomarkers Prev, 14(7): 1724-31. [Abstract] [Full-text]
23. Thromboembolism during hormone therapy in Japanese women.
    Semin Thromb Hemost, 31(3): 272-80. [Abstract] [Full-text]
24. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Womens Health Issues, 15(4): 187-95. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.